Biomerica, Inc. (BMRA)
2.09
+0.04
(+1.95%)
USD |
NASDAQ |
Oct 06, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
Biomerica Free Cash Flow : -3.422M for May 31, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| May 31, 2026 | -3.422M |
| February 28, 2026 | -3.189M |
| November 30, 2025 | -2.969M |
| August 31, 2025 | -2.802M |
| May 31, 2025 | -3.878M |
| February 28, 2025 | -4.285M |
| November 30, 2024 | -5.053M |
| August 31, 2024 | -5.083M |
| May 31, 2024 | -5.476M |
| February 29, 2024 | -5.385M |
| November 30, 2023 | -5.299M |
| August 31, 2023 | -5.682M |
| May 31, 2023 | -5.552M |
| February 28, 2023 | -8.857M |
| November 30, 2022 | -4.786M |
| August 31, 2022 | -2.256M |
| May 31, 2022 | -0.6508M |
| February 28, 2022 | 2.552M |
| November 30, 2021 | -1.252M |
| August 31, 2021 | -3.859M |
| May 31, 2021 | -5.547M |
| February 28, 2021 | -8.030M |
| November 30, 2020 | -7.032M |
| August 31, 2020 | -6.084M |
| May 31, 2020 | -4.416M |
| Date | Value |
|---|---|
| February 29, 2020 | -1.893M |
| November 30, 2019 | -1.716M |
| August 31, 2019 | -1.620M |
| May 31, 2019 | -2.415M |
| February 28, 2019 | -1.755M |
| November 30, 2018 | -1.974M |
| August 31, 2018 | -1.977M |
| May 31, 2018 | -1.304M |
| February 28, 2018 | -1.260M |
| November 30, 2017 | -0.9016M |
| August 31, 2017 | -0.8917M |
| May 31, 2017 | -0.819M |
| February 28, 2017 | -0.5232M |
| November 30, 2016 | -0.1833M |
| August 31, 2016 | -0.1746M |
| May 31, 2016 | -0.304M |
| February 29, 2016 | -0.3544M |
| November 30, 2015 | -1.046M |
| August 31, 2015 | -0.7574M |
| May 31, 2015 | -0.416M |
| February 28, 2015 | -0.3568M |
| November 30, 2014 | -0.0001M |
| August 31, 2014 | -0.4746M |
| May 31, 2014 | -0.9995M |
| February 28, 2014 | -1.08M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Univec, Inc. | -15.55M |
| Lantheus Holdings, Inc. | 382.42M |
| Zomedica Corp. | -14.80M |
| IDEXX Laboratories, Inc. | 1.233B |
| Neogen Corp. | 31.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.912M |
| Cash from Investing (Quarterly) | 0.018M |
| Cash from Financing (Quarterly) | 0.871M |
| Free Cash Flow Per Share (Quarterly) | -0.2912 |
| Free Cash Flow to Equity (Quarterly) | -3.084M |
| Free Cash Flow to Firm (Quarterly) | -0.894M |
| Free Cash Flow Yield | -56.32% |